Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype

Area of Science:

• Comparative oncology
• Mitochondrial biology
• Cancer genetics

Background:

• Osteosarcoma (OSA) is an aggressive bone cancer affecting children and dogs.
• Canine OSA serves as a valuable comparative model due to shared biological features with human OSA.
• The role of mitochondrial (mt) defects in OSA progression and metastasis remains unclear.

Purpose of the Study:

• Investigate the impact of mitochondrial DNA (mtDNA) content and dysfunction on osteosarcoma biology using a comparative approach.
• Determine if mitochondrial defects are associated with OSA invasiveness and metastasis.
• Explore mitochondrial defects as potential prognostic biomarkers and therapeutic targets for OSA.

Main Methods:

• Comparative analysis of canine OSA cell lines and tumor tissues.
• Quantification of mtDNA content and assessment of mitochondrial respiration.
• Evaluation of mitochondrial morphology and expression of key signaling proteins.
• Induction of mtDNA depletion using Ethidium Bromide to establish causality.

Main Results:

• OSA tumor tissues exhibited lower mtDNA content compared to non-tumor tissues.
• Invasive OSA cell lines showed increased mitochondrial defects, including reduced mtDNA copies, impaired respiration, and altered mitochondrial morphology.
• Expression of specific mitochondrial retrograde signaling proteins correlated with OSA cell invasiveness.
• Ethidium Bromide-induced mtDNA depletion causally linked mitochondrial defects to the invasive phenotype.

Conclusions:

• Mitochondrial genome and function defects are prevalent in osteosarcoma.
• Lower mtDNA content is associated with increased tumor cell invasiveness in OSA.
• Mitochondrial defects represent a potential prognostic biomarker and therapeutic target for osteosarcoma.